News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
16-Mar-2005 - Sanofi-aventis has learned through the Canadian Ministry of Health website that Novopharm Limited has obtained marketing approval in Canada for a product claiming to be generic enoxaparin. Sanofi-aventis companies Aventis Pharma Inc. and Aventis Pharma S.A. are bringing suit in the Federal Court ...
01-Mar-2005 - The mission of the sanofi-aventis European Works Council is to ensure that employees in the European countries covered by this agreement are informed and consulted, in good time, on the Group's strategic options, on economic, social and financial issues or prospects which require treatment at ...
10-Feb-2005 - Barr Pharmaceuticals, Inc. announced that its subsidiary, Barr Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration (FDA) in the United States District Court for the District of Columbia. Barr's suit challenges FDA's policy of awarding generic exclusivity on a ...
26-Jan-2005 - Sanofi-aventis has been notified that its patent in the UK issued from its European Patent claiming the active ingredient in its Plavix(R) product has been challenged by Aircoat, Ltd., a Scottish company. Sanofi-aventis believes Aircoat's arguments to be without merit, and will vigorously defend ...
24-Jan-2005 - According to a decision by the European Commission, various producers of MCAA (monochloroacetic acid), an organic chemical used as intermediate in the manufacture of various products, have been fined. This decision was made further to an investigation regarding alleged arrangements affecting ...
02-Dec-2004 - Tripos, Inc. announced that it has entered a strategic partnership with Sanofi-Synthelabo Recherche, an affiliate of Sanofi-Aventis. Sanofi-Synthelabo Recherche has identified a number of proprietary chemistry motifs that exhibit therapeutic potential in a wide range of target areas. Tripos will ...
26-Nov-2004 - Since April 26, 2004, when Sanofi-Synthélabo and Aventis agreed to create sanofi-aventis, it has been confirmed that the headquarters of the new sanofi-aventis Group is to be located in Paris. Sanofi-aventis announced today that the Aventis site located in Schiltigheim will cease its activity ...
02-Apr-2004 - Aventis announced that the divestment of the therapeutic proteins business Aventis Behring to CSL Limited was completed on March 31, 2004. In this transaction, CSL Limited has acquired Aventis Behring, its subsidiaries and the plasma activities in Japan, previously held by Aventis Pharma ...
09-Mar-2004 - 03/08/2004 Aventis and Bayer Reach Agreement on Final Purchase Price of CropScience Business Aventis Press Release Strasbourg, France - Aventis and Bayer CropScience AG, have reached agreement on the final purchase price for Aventis CropScience that Bayer acquired in June 2002 after ...
05-Nov-2003 - Aventis announced that it has divested its entire 11.85% holding in the Swiss chemical company Clariant as part of its strategy to focus on pharmaceuticals. The sale was made to selected institutional investors at a price of CHF 19.25 per share.
© 1997-2024 LUMITOS AG, All rights reserved